Does an Abdominal MRI Show the Intestines?

An abdominal MRI does show the intestines, though the level of detail varies considerably depending on the type of scan ordered and how you prepare for it. A routine abdominal MRI requested for, say, a liver or kidney problem will capture the bowel in the background, often well enough to spot something obviously abnormal. But when the intestines themselves are the focus, radiologists use specialized protocols with oral contrast drinks and specific imaging sequences that turn the gut into a remarkably detailed map of tissue, inflammation, and blood flow.

What a Routine Abdominal MRI Shows

If your doctor orders a general abdominal MRI to evaluate your liver, gallbladder, pancreas, or kidneys, the intestines will appear in those images. Loops of small bowel and segments of colon show up because they physically sit in the same space being scanned. A radiologist reviewing those images can often identify gross abnormalities like a large mass, obvious thickening of the bowel wall, free fluid suggesting a perforation, or dilated loops suggesting an obstruction.

That said, the intestines are not the star of the show on a routine scan. Without special preparation, the bowel lumen is often collapsed or filled with variable amounts of fluid and air, which makes the wall hard to evaluate in detail. The gut is also constantly moving. Peristalsis, the rhythmic squeezing that pushes food along, creates blurring and ghost artifacts on MR images that can obscure findings or even mimic lesions that aren’t there.¹ So a standard abdominal MRI gives you intestines in the frame, but not necessarily intestines at their best.

MR Enterography Changes the Game

When the clinical question specifically involves the small bowel, the exam of choice is MR enterography, or MRE. This is a dedicated MRI protocol designed from the ground up to visualize the intestinal wall and the tissues around it. MRE has become a go-to tool for evaluating conditions like Crohn’s disease, providing a radiation-free way to look at inflammation, strictures, fistulas, and abscesses.²

The difference between a routine MRI and an MRE is a bit like the difference between glancing at a house from the street and walking through every room with a flashlight. MRE uses multiple imaging sequences tailored to highlight different tissue characteristics. Some sequences make fluid inside the bowel look bright, which silhouettes the wall and reveals thickening or ulceration. Others are timed after an intravenous contrast injection to show how avidly the wall is enhancing, a direct marker of active inflammation.

Why You Have to Drink All That Liquid

One of the most important steps in MRE happens before you even get on the table. You’ll typically be asked to drink a large volume of oral contrast, often around a liter or more, over the hour before the scan. The purpose is to distend the bowel lumen so the wall can be clearly seen. A collapsed loop of intestine hides its wall layers, making it nearly impossible to tell normal from abnormal. Oral contrast agents used in MRE can be classified by how they behave on different MRI sequences. The most commonly used agents appear bright on one type of image and dark on another, which gives the radiologist flexibility to evaluate the wall from multiple angles.³

Bowel distension and motion artifacts are the two main factors that determine image quality on MRE.⁴ Patients who can’t tolerate drinking the full volume, or whose bowel doesn’t distend well, may end up with suboptimal images. Some centers use rectal contrast instead of or in addition to oral contrast, particularly when the colon or terminal ileum is the area of interest.

Dealing With a Moving Target

Your intestines don’t hold still for portraits. Peristalsis is constant, and on MRI, where image acquisition takes longer than a CT snapshot, that motion smears the picture. Radiologists have two main strategies to deal with this: faster imaging sequences and drugs that temporarily pause bowel movement.

Antispasmodic medications given by injection just before the scan can quiet the gut long enough to capture clean images. Two commonly used drugs are hyoscine butylbromide (sold as Buscopan in many countries) and glucagon. They work differently, and their effectiveness isn’t identical. In a head-to-head comparison, glucagon reliably stopped small bowel motion and its effect lasted roughly 18 minutes on average, whereas hyoscine butylbromide failed to achieve full arrest of motion in half of patients and lasted only about 7 minutes when it did work.⁵ In the United States, where Buscopan isn’t approved, glucagon is the standard choice. In Europe and elsewhere, Buscopan is widely available and cheaper, so it tends to be used first despite its shorter window of effectiveness.

Anticholinergic drugs like oral dicyclomine have also been shown to reduce the ghost artifacts caused by peristalsis.¹ The choice of antispasmodic often comes down to local availability, cost, and patient tolerance.

How MRI Compares to CT for Bowel Imaging

CT is faster, more widely available, and often the first-line imaging choice for acute abdominal problems. So where does MRI fit in? For many intestinal conditions, the two perform similarly. In a direct comparison for small bowel Crohn’s disease, MR enterography and CT enterography had comparable sensitivity for detecting active disease, at roughly 91% and 95% respectively, a difference that was not statistically meaningful.⁶ Image quality scores did favor CT, largely because CT acquisitions are so fast that motion is rarely a problem.

An older comparison found that MRI was nearly equivalent to CT for detecting masses, bowel wall abnormalities, and small bowel obstruction, though it fell short for omental lesions. For inflammatory bowel disease specifically, MRI actually provided more information than CT in half the cases studied.⁷ MRI’s superior soft-tissue contrast is a real advantage when it comes to characterizing inflammation and distinguishing active disease from scarring, a distinction that changes treatment decisions.

For acute small bowel obstruction, plain X-rays remain the first step and CT is the workhorse when more detail is needed. MRI currently plays a secondary role in acute obstruction because CT is faster and more accessible in emergency settings.⁸ Where MRI really wins is in situations where repeated imaging is expected over time and cumulative radiation is a concern, or when radiation must be avoided altogether.

Crohn’s Disease and Inflammatory Bowel Disease

This is the single biggest reason MRE exists. Crohn’s disease tends to affect the small bowel, a stretch of gut that is notoriously hard to reach with standard endoscopy. MRI can show wall thickening, abnormal contrast enhancement indicating active inflammation, narrowing of the lumen from strictures, and complications like fistulas (abnormal tunnels between organs) and abscesses. These findings directly influence whether a patient is managed with medications, sent to surgery, or kept on observation.⁹

Capsule endoscopy, where you swallow a tiny camera that photographs the bowel lining as it travels through, can spot superficial mucosal lesions that MRI might miss. But MRI has the advantage of seeing through the wall and beyond it. It can identify transmural (full-thickness) disease and extraluminal complications that a capsule camera, which only sees the surface, cannot detect. The two methods are genuinely complementary rather than competitive.¹⁰ Capsule endoscopy also carries a risk of getting stuck behind a stricture, which is exactly the kind of thing MRI can identify in advance.

The Large Bowel and Rectum

MRI isn’t limited to the small intestine. MR colonography is a technique designed to image the colon, and it performs well for detecting larger polyps. For polyps 10 mm or larger, per-patient sensitivity was around 88-89%, with specificity above 96%.¹¹ A systematic review of prospective studies confirmed similar numbers, finding per-patient sensitivity of 88% and specificity of 99% for polyps at least 10 mm across.¹² For smaller polyps, accuracy drops. Colonoscopy remains the standard for colon cancer screening because it can both find and remove polyps in the same procedure, but MR colonography offers value for patients who cannot undergo or refuse conventional colonoscopy.

Rectal MRI deserves special mention. For rectal cancer, MRI is the primary staging tool used worldwide. It gives the surgical team a detailed picture of the tumor’s depth of invasion, its relationship to the mesorectal fascia (the resection margin that determines surgical approach), lymph node involvement, and whether the tumor has invaded blood vessels.¹³ This information is critical for deciding whether a patient goes straight to surgery or receives chemotherapy and radiation first.

When MRI Is the Preferred Choice

Pregnancy is perhaps the clearest case. When a pregnant patient presents with right lower quadrant pain and appendicitis is suspected, CT means radiation to the fetus, which everyone wants to avoid. MRI has stepped into this role with impressive results. A meta-analysis found that MRI had a sensitivity of 94% and specificity of 97% for acute appendicitis in pregnant patients.¹⁴ In one study focused exclusively on pregnant women, sensitivity reached 100%.¹⁵

Children are another group where MRI’s lack of ionizing radiation matters. Kids with Crohn’s disease may need dozens of imaging studies over a lifetime. Each CT adds to their cumulative radiation exposure. MRE allows serial monitoring without that cost, and the diagnostic performance in children is strong, with sensitivity and specificity for appendicitis both around 96%.¹⁴

Blood Supply and Mesenteric Ischemia

The intestines depend on a rich blood supply through the mesenteric arteries, and when that supply is compromised, the consequences can be severe. MR angiography can image the mesenteric vessels and plays a role in the workup when ischemia is suspected.¹⁶ Beyond just looking at the vessels, researchers have shown it’s possible to measure bowel wall perfusion on MRI by tracking how contrast material enhances the intestinal wall over time. This approach could help distinguish ischemic bowel from normal bowel before tissue damage becomes irreversible.¹⁷ CT angiography currently dominates in the acute setting because of its speed, but MRI is a viable alternative when CT isn’t an option.

Surprise Findings Along the Way

When MRE is performed for a known condition like Crohn’s disease, the scan frequently picks up things no one was looking for. In one large study, about a quarter of patients undergoing MRE had extra-intestinal findings unrelated to their Crohn’s disease. Around 20% had previously unknown lesions, and about 6% had findings that were clinically important or needed further workup. Ultimately, roughly 3% of patients required additional interventions based on these incidental discoveries, including one case that turned out to be a previously undiagnosed malignancy.¹⁸ This is worth knowing if you’re having an MRE: there’s a small but real chance the scan will flag something outside the intestines that needs attention.

Using MRI to Watch the Gut Move

One genuinely unique capability of MRI is its ability to film the intestines in real time. Cine MRI captures rapid sequences of images that show peristaltic contractions as they happen, turning the gut’s motion into a measurable parameter rather than just an artifact to suppress. Research has determined that capturing images at a rate of one frame per second provides a stable motility index for both localized and global intestinal movement.¹⁹

This is more than a curiosity. Inflamed bowel segments in Crohn’s disease tend to move abnormally, either too sluggishly or with a disrupted pattern. In patients starting biological therapy for Crohn’s disease, motility measured on cine MRI was tested as a predictor of treatment response at one year. Stable or improved motility on MRI at an early follow-up visit was more sensitive than a standard blood marker for predicting which patients would maintain their response, though it was less specific, meaning it flagged some patients as likely responders who turned out not to be.²⁰ The ability to quantify how the gut moves, not just how it looks, could eventually help clinicians decide sooner whether a treatment is working.

Where Artificial Intelligence Fits In

Interpreting MRE scans is time-consuming and requires specialized expertise. Deep learning algorithms are being developed to automate parts of the process. Recent work has applied neural networks to improve image quality, segment bowel from surrounding tissue, measure intestinal motility, assess inflammation, and even create three-dimensional reconstructions of complex anatomy like perianal fistulas.²¹ These tools are still largely in the research phase, but they point toward a future where AI assists the radiologist in extracting more information from each scan and potentially reduces the variability in interpretation between different readers. For patients, the practical implication is that MRE may become faster to interpret and more consistent in quality as these tools mature.

1
PubMed. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs
2
PubMed Central. Magnetic resonance enterography: A stepwise interpretation approach and role of imaging in management of adult Crohn’s disease
3
Radiología (English Edition). Contrast agents for MR enterography
4
PubMed Central. Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease
5
PubMed. Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imaging
6
PubMed. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn’s disease
7
Europe PMC / Korean Journal of Radiology. Usefulness of MR imaging for diseases of the small intestine: comparison with CT
8
PubMed. Imaging of acute small-bowel obstruction
9
PubMed. MR enterography of Crohn disease: part 2, imaging and pathologic findings
10
Gut. Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis
11
PubMed. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy
12
PubMed Central. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies
13
RadioGraphics. MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management
14
PubMed. A Systematic Review and Meta-Analysis of Diagnostic Performance of MRI for Evaluation of Acute Appendicitis
15
PubMed Central. MRI as First Line Imaging for Suspected Acute Appendicitis during Pregnancy: Diagnostic Accuracy and level of Inter-radiologist Agreement
16
PubMed. CTA and MRA in mesenteric ischemia: part 1, Role in diagnosis and differential diagnosis
17
PubMed. MR imaging of apparent small-bowel perfusion for diagnosing mesenteric ischemia: feasibility study
18
Europe PMC / World Journal of Gastroenterology. Incidental findings at MRI-enterography in patients with suspected or known Crohn’s disease
19
PubMed Central. Dynamic MRI for bowel motility imaging—how fast and how long?
20
Inflammatory Bowel Diseases. Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study
21
PubMed Central. Deep learning in magnetic resonance enterography for Crohn’s disease assessment: a systematic review